CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Maxillary sinus augmentationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03899688
NCT03899688N/ACompleted

Cone Beam Computed Tomography and Histomorphometric Assessments on the Influence a Collagen Membrane Placed on the Antrostomy After Maxillary Sinus Floor Augmentation. A Randomized Clinical Trial.

ARDEC Academy·interventional·Posted Apr 2, 2019·Updated Jan 20, 2022

In Brief

A clinical study evaluating Maxillary sinus augmentation for Alveolar Bone Loss and Alveolar Bone Resorption. Completed, enrolled 20 participants across 1 site.

Detailed Summary

the aim of the present study was to evaluate the dimensional variation and osseointegration of mini-implants at augmented sinus with the antrostomy left unprotected or protected with a collagen membrane.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesColombia
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 2, 2019
Enrollment StartFeb 20, 2015
Primary CompletionDec 21, 2018
Study CompletionMar 2, 2019
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 7.3 years ago

Interventions

Maxillary sinus augmentationprocedure

Surgical technique for increasing the vertical bone height of the posterior maxilla an antrostomy of about 5 mm in height and 10 mm long will be prepared using a diamond insert mounted on a sonic-air surgical instrument. The Schneiderian membrane will be elevated and clinical measurements will be performed using an UNC 15 probe. The space obtained underneath the sinus mucosa will be filled with the xenograft and a resorbable collagen membrane will be placed to cover the antrostomy only at the randomly selected control sites.